Fadi Fakhouri

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


195 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
In press
 
Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome.
Schwotzer N., Fakhouri F., Martins P.V., Delmas Y., Caillard S., Zuber J., Moranne O., Mesnard L., Frémeaux-Bacchi V., El-Sissy C. American journal of kidney diseases. Peer-reviewed.
[DOI][Pmid][serval:BIB_8B36905C32DA]
2024
 
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.
Maisons V., Duval A., Mesnard L., Frimat M., Fakhouri F., Grangé S., Servais A., Cartery C., Fauchier L., Coppo P. et al., 2024/05. Kidney international, 105 (5) pp. 1100-1112. Peer-reviewed.
[DOI][Pmid][serval:BIB_9A8D1EA78FBB]
 
The Case | Acute kidney injury in a patient with systemic necrotizing lesions.
Kissling S., Rotman S., Fakhouri F., 2024/05. Kidney international, 105 (5) pp. 1133-1134. Peer-reviewed.
[DOI][Pmid][serval:BIB_2CAA65B912D5]
 
Néphrologie de précision.
De Seigneux S., Fakhouri F., 2024/02/28. Revue medicale suisse, 20 (863) p. 419. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4C4F8CB98A0B]
 
Pregnancy as a susceptible state for thrombotic microangiopathies.
Frimat M., Gnemmi V., Stichelbout M., Provôt F., Fakhouri F., 2024. Frontiers in medicine, 11 p. 1343060. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E4D4F681F85]
2023
Atypical cystic hepatorenal disease in a 40-year-old female: What is the diagnosis? A nephrology zebra.
Barbey F., Maillard M., Cina V., Fakhouri F., 2023/12. Journal of nephrology, 36 (9) pp. 2651-2653. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EDE08B2F7EAB]
A Policy Call to Address Rare Kidney Disease in Health Care Plans.
Vanholder R., Coppo R., Bos WJW, Damato E., Fakhouri F., Humphreys A., Nistor I., Ortiz A., Pistollato M., Scheres E. et al., 2023/11/01. Clinical journal of the American Society of Nephrology, 18 (11) pp. 1510-1518. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E9E3AF30D72]
 
Targeting the Complement Pathway in Kidney Transplantation.
Golshayan D., Schwotzer N., Fakhouri F., Zuber J., 2023/11/01. Journal of the American Society of Nephrology, 34 (11) pp. 1776-1792. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F71F0C87493]
Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology.
Von Tokarski F., Fillon A., Maisons V., Thoreau B., Bayer G., Gatault P., Longuet H., Sautenet B., Buchler M., Vigneau C. et al., 2023/09/20. BMC nephrology, 24 (1) p. 278. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_78DE94C96F85]
Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome.
Kavanagh D., Greenbaum L.A., Bagga A., Karki R.G., Chen C.W., Vasudevan S., Charney A., Dahlke M., Fakhouri F., 2023/07. Kidney international reports, 8 (7) pp. 1332-1341. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1375C4F64064]
 
Prise en charge des maladies rénales génétiques : expérience locale et importance du réseau [Management of genetic renal disorders: local experience and importance of the network]
Bonny O., Ketterer A., Hermida S., Superti-Furga A., Venetz J.P., Chehade H., Fodstad H., Cina V., Parvex P., Paoloni-Giacobino A. et al., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1245-1249. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9C5896980D20]
 
Hemolytic Uremic Syndrome: A Question of Terminology.
Schwotzer N., Frémeaux-Bacchi V., Fakhouri F., 2023/05/29. Clinical journal of the American Society of Nephrology, 18 (7) pp. 831-833. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96ABFE99CAA2]
 
How I diagnose and treat atypical hemolytic uremic syndrome.
Fakhouri F., Schwotzer N., Frémeaux-Bacchi V., 2023/03/02. Blood, 141 (9) pp. 984-995. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_05099DE4C4DC]
 
La néphrologie : une spécialité de maladies rares.
Fakhouri F., De Seigneux S., 2023/03/01. Revue medicale suisse, 19 (816) p. 395. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AA0ACD6946E6]
 
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management.
Fakhouri F., Schwotzer N., Cabiddu G., Barratt J., Legardeur H., Garovic V., Orozco-Guillen A., Wetzels J., Daugas E., Moroni G. et al., 2023/02. Kidney international, 103 (2) pp. 264-281. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FC0ACA8AF622]
Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease.
Trucello L., Nobre D., Sabaratnam V., Bonny O., Wuerzner G., Burnier M., Fakhouri F., Pruijm M., Zanchi A., 2023. Frontiers in cardiovascular medicine, 10 p. 1230227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_199BBB7CA1E4]
2022
 
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
Lomax-Browne H.J., Medjeral-Thomas N.R., Barbour S.J., Gisby J., Han H., Bomback A.S., Fervenza F.C., Cairns T.H., Szydlo R., Tan S.J. et al., 2022/07. Clinical journal of the American Society of Nephrology, 17 (7) pp. 994-1007. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C363C4B1A535]
 
Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies.
Figueres L., Bruneau S., Prot-Bertoye C., Brideau G., Néel M., Griveau C., Cheval L., Bignon Y., Dimitrov J., Dejoie T. et al., 2022/07. Journal of the American Society of Nephrology, 33 (7) pp. 1402-1410. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2277A9AE7D7D]
The Rational Use of Complement Inhibitors in Kidney Diseases.
Fakhouri F., Schwotzer N., Golshayan D., Frémeaux-Bacchi V., 2022/06. Kidney international reports, 7 (6) pp. 1165-1178. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6B98D384D8F5]
Nouveautés dans la pathophysiologie et le traitement de l’anémie rénale [New insights in the pathophysiology and treatment of renal anemia]
Vultaggio P., Loria F., Fakhouri F., Leuenberger N., Pruijm M., 2022/03/02. Revue medicale suisse, 18 (771) pp. 358-363. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C48E5B4F4AB8]
Vingt ans de néphrologie à Genève []
Martin P.Y., De Seigneux S., Fakhouri F., 2022/03/02. Revue medicale suisse, 18 (771) pp. 355-356. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8FAC22D06D91]
 
What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study.
Halimi J.M., Thoreau B., von Tokarski F., Bauvois A., Gueguen J., Goin N., Barbet C., Cloarec S., Mérieau E., Lachot S. et al., 2022/01/20. BMC nephrology, 23 (1) p. 39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D876EC19E052]
Prevalence and Factors Associated with Opioid Prescription in Swiss Chronic Hemodialysis Patients
Hennebel Clémence, Vilmont Valérie, Cherpillod Anne, Fumeaux David, Fakhouri Fadi, Livio Françoise, Burnier Michel, Pruijm Menno, 2022/01/02. Kidney and Dialysis, 2 (1) pp. 6-15.
[URN][DOI][serval:BIB_01CCFE785454]
 
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification
Ronsin C., Georges M., Chapelet-Debout A., Augusto J. F., Audard V., Lebourg L., Rubin S., Quemeneur T., Bataille P., Karras A. et al., 2022/01. Am J Kidney Dis, 79 (1) pp. 56-68 e1.
[DOI][Pmid][serval:BIB_6B6C00AAE259]
 
Pregnancy in Women with Atypical Hemolytic Uremic Syndrome
Rondeau E., Ardissino G., Caby-Tosi M. P., Al-Dakkak I., Fakhouri F., Miller B., Scully M., H. U. S. Registry HUS, 2022. Nephron, 146 (1) pp. 1-10.
[DOI][Pmid][serval:BIB_4AC480849F5B]
2021
 
COVID-19 as a potential trigger of complement-mediated atypical HUS.
El Sissy C., Saldman A., Zanetta G., Martins P.V., Poulain C., Cauchois R., Kaplanski G., Venetz J.P., Bobot M., Dobosziewicz H. et al., 2021/11/04. Blood, 138 (18) pp. 1777-1782. Peer-reviewed.
[DOI][Pmid][serval:BIB_6916C0B7F2B4]
A stone in the bone.
Halfon M., Cochat P., Kissling S., Dattner N., de Leval L., Fakhouri F., Pruijm M., Bonny O., 2021/11. JIMD reports, 62 (1) pp. 6-8. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5CF3D22FA261]
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
Fakhouri F., Scully M., Ardissino G., Al-Dakkak I., Miller B., Rondeau E., 2021/10. Journal of nephrology, 34 (5) pp. 1581-1590. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E6E714EA0EEA]
Hypertension artérielle sévère ou urgence hypertensive : du cabinet à l’hôpital [Severe asymptomatic hypertension and hypertensive emergency : From the ambulatory care to the emergency room]
Berney M., Fakhouri F., Wuerzner G., 2021/09/15. Revue medicale suisse, 17 (750) pp. 1549-1555. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E86597CEBB3A]
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_286BB643A89B]
 
Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation.
Thoreau B., von Tokarski F., Bauvois A., Bayer G., Barbet C., Cloarec S., Mérieau E., Lachot S., Garot D., Bernard L. et al., 2021/09. Clinical journal of the American Society of Nephrology, 16 (9) pp. 1355-1364. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6867E54B1B0]
Letter regarding "Minimal change disease relapse following SARS-CoV-2 mRNA vaccine".
Schwotzer N., Kissling S., Fakhouri F., 2021/08. Kidney international, 100 (2) pp. 458-459. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_323BC15064FE]
 
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.
Fakhouri F., Frémeaux-Bacchi V., 2021/08. Nature reviews. Nephrology, 17 (8) pp. 543-553. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3B57D9085A1]
 
Malignant hypertension and thrombotic microangiopathy: complement as a usual suspect.
Fakhouri F., Sadallah S., Frémeaux-Bacchi V., 2021/07/31. Nephrology, dialysis, transplantation, 36 (7) pp. 1157–1159. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53FA5B34FA38]
Eosinophilia Due to Central Venous Catheter in Hemodialysis Patients.
Chapelet-Debout A., Coupel S., de Geyer d'Orth G., Gourraud-Vercel C., Lefrançois G., Parahy S., Deltombe C., Ville S., Fakhouri F., 2021/04. Kidney international reports, 6 (4) pp. 1189-1191. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B82712793B08]
Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes.
Schwotzer N., Provot F., Ville S., Daniel L., Le Fur A., Kissling S., Jourde-Chiche N., Karras A., Moreau A., Augusto J.F. et al., 2021/03. Kidney international reports, 6 (3) pp. 746-754. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_95B38036CCD6]
Complément et rein [Complement system and kidney]
Halfon M., Pascual M., Sadallah S., Fakhouri F., 2021/02/24. Revue medicale suisse, 17 (727) pp. 383-388. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_83627E067A3D]
Le prix de l’innovation en néphrologie []
Fakhouri F., Martin P.Y., 2021/02/24. Revue medicale suisse, 17 (727) p. 371. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8C1C232656A1]
Atypical HUS relapse triggered by COVID-19.
Ville S., Le Bot S., Chapelet-Debout A., Blancho G., Fremeaux-Bacchi V., Deltombe C., Fakhouri F., 2021/01. Kidney international, 99 (1) pp. 267-268. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4C409663DAAC]
 
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study
Fakhouri F., Fila M., Hummel A., Ribes D., Sellier-Leclerc A. L., Ville S., Pouteil-Noble C., Coindre J. P., Le Quintrec M., Rondeau E. et al., 2021. Blood, 137 (18) pp. 2438-2449.
[DOI][Pmid][serval:BIB_E11AC30A8988]
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017
Travert B., Dossier A., Jamme M., Cointe A., Delmas Y., Malot S., Wynckel A., Seguin A., Presne C., Hie M. et al., 2021. Emerg Infect Dis, 27 (7) pp. 1876-1885.
[URN][DOI][Pmid][serval:BIB_6B143340E4F3]
2020
 
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
Fakhouri F., Scully M., Provôt F., Blasco M., Coppo P., Noris M., Paizis K., Kavanagh D., Pène F., Quezada S. et al., 2020/11/05. Blood, 136 (19) pp. 2103-2117. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_307584AB9C47]
 
Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties.
Fakhouri F., Le Quintrec M., Frémeaux-Bacchi V., 2020/11. Kidney international, 98 (5) pp. 1135-1148. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E003289D80CB]
 
Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations.
Sichitiu J., Fakhouri F., Desseauve D., 2020/07. Acta obstetricia et gynecologica Scandinavica, 99 (7) p. 952. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EC0EF3A5EE8D]
Collapsing glomerulopathy in a COVID-19 patient.
Kissling S., Rotman S., Gerber C., Halfon M., Lamoth F., Comte D., Lhopitallier L., Sadallah S., Fakhouri F., 2020/07. Kidney international, 98 (1) pp. 228-231. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_251429356BF9]
The authors reply.
Kissling S., Rotman S., Fakhouri F., 2020/07. Kidney international, 98 (1) p. 232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1AB99740E571]
Spondyloarthritis-Associated IgA Nephropathy
Champtiaux N., Liote F., El Karoui K., Vigneau C., Miceli C., Cornec-Le Gall E., Remy P., Choukroun G., Fakhouri F., Garrouste C. et al., 2020/06. Kidney Int Rep, 5 (6) pp. 813-820.
[URN][DOI][Pmid][serval:BIB_7BA74A3CA463]
 
The Case | A neoplastic cause of acute kidney injury
Garandeau C., Figueres L., Renaudin K., Fakhouri F., 2020/03. Kidney Int, 97 (3) pp. 621-622.
[DOI][Pmid][serval:BIB_1AF278031B4B]
 
The Presence of Renal IgG Deposits in Necrotizing Crescentic Glomerulonephritis Associated with ANCA Is Not Related to Worse Renal Clinical Outcomes
Dudreuilh C., Fakhouri F., Vigneau C., Augusto J. F., Machet M. C., Rabot N., Chapal M., Charpy V., Barbet C., Buchler M. et al., 2020/03. Kidney Dis (Basel), 6 (2) pp. 98-108.
[DOI][Pmid][serval:BIB_AFE2027F409A]
Des changements en vue…
Martin P.Y., Wuerzner G., Fakhouri F., 2020/02/26. Revue medicale suisse, 16 (683) pp. 387-388. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7EC1B0B668EE]
Les reins : cibles du réchauffement climatique ? [The kidneys : possible victims of global warming ?]
Ngatchou N., Martin P.Y., Fakhouri F., Pruijm M., 2020/02/26. Revue medicale suisse, 16 (683) pp. 412-416. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_281EBCC6D830]
 
Antimicrobial Activity and GC-MS Profile of Copaiba Oil for Incorporation into Xanthosoma mafaffa Schott Starch-Based Films
Rodrigues G. M., Filgueiras C. T., Garcia Vads, Carvalho R. A., Velasco J. I., Fakhouri F. M., 2020. Polymers (Basel), 12 (12).
[URN][DOI][Pmid][serval:BIB_B8EFB8A75886]
 
C3 glomerulonephritis in a patient treated with anti-PD-1 antibody
Ville S., Kandel-Aznar C., Fremeaux-Bacchi V., Fakhouri F., 2020/01. Eur J Cancer, 125 pp. 46-48.
[DOI][Pmid][serval:BIB_35FF05D27AA6]
2019
 
Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies.
Fakhouri F., Frémeaux-Bacchi V., 2019/12/06. Clinical journal of the American Society of Nephrology, 14 (12) pp. 1682-1683. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3DE7895043A0]
Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
El Karoui K., Boudhabhay I., Petitprez F., Vieira-Martins P., Fakhouri F., Zuber J., Aulagnon F., Matignon M., Rondeau E., Mesnard L. et al., 2019/12. Haematologica, 104 (12) pp. 2501-2511.
[URN][DOI][Pmid][serval:BIB_FD3A886AB419]
 
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome in solid organ transplant recipients
Ville S., Ydee A., Garandeau C., Canet E., Tissot A., Cantarovich D., Fremeaux-Bacchi V., Mariani-Kurkdjian P., Provot F., Fakhouri F., 2019/12. Kidney Int, 96 (6) pp. 1423-1424.
[DOI][Pmid][serval:BIB_366F1507F1AA]
 
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
Zuber J., Frimat M., Caillard S., Kamar N., Gatault P., Petitprez F., Couzi L., Jourde-Chiche N., Chatelet V., Gaisne R. et al., 2019/12. J Am Soc Nephrol, 30 (12) pp. 2449-2463.
[DOI][Pmid][serval:BIB_EC5E85984A2B]
 
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
Le Clech A., Simon-Tillaux N., Provot F., Delmas Y., Vieira-Martins P., Limou S., Halimi J. M., Le Quintrec M., Lebourg L., Grange S. et al., 2019/06. Kidney Int, 95 (6) pp. 1443-1452.
[DOI][Pmid][serval:BIB_4A7C9A825EB6]
 
Dampening of CD8+ T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Neel A., Bucchia M., Neel M., Tilly G., Caristan A., Yap M., Rimbert M., Bruneau S., Cadoux M., Agard C. et al., 2019/04. Arthritis Rheumatol, 71 (4) pp. 641-650.
[DOI][Pmid][serval:BIB_7A2FA517CB4E]
Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study
Menne J., Delmas Y., Fakhouri F., Kincaid J. F., Licht C., Minetti E. E., Mix C., Provot F., Rondeau E., Sheerin N. S. et al., 2019/04. Clin Kidney J, 12 (2) pp. 196-205.
[URN][DOI][Pmid][serval:BIB_F12D4F15201E]
 
C3 glomerulopathy - understanding a rare complement-driven renal disease
Smith R. J. H., Appel G. B., Blom A. M., Cook H. T., D'Agati V. D., Fakhouri F., Fremeaux-Bacchi V., Jozsi M., Kavanagh D., Lambris J. D. et al., 2019/03. Nat Rev Nephrol, 15 (3) pp. 129-143.
[DOI][Pmid][serval:BIB_ACB8186CB94F]
 
Endothelium structure and function in kidney health and disease
Jourde-Chiche N., Fakhouri F., Dou L., Bellien J., Burtey S., Frimat M., Jarrot P. A., Kaplanski G., Le Quintrec M., Pernin V. et al., 2019/02. Nat Rev Nephrol, 15 (2) pp. 87-108.
[DOI][Pmid][serval:BIB_721ECA339A7B]
 
Etiology and Outcomes of Thrombotic Microangiopathies
Bayer G., von Tokarski F., Thoreau B., Bauvois A., Barbet C., Cloarec S., Merieau E., Lachot S., Garot D., Bernard L. et al., 2019. Clin J Am Soc Nephrol, 14 (4) pp. 557-566.
[DOI][Pmid][serval:BIB_5DA6736FF4C0]
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study
Menne J., Delmas Y., Fakhouri F., Licht C., Lommele A., Minetti E. E., Provot F., Rondeau E., Sheerin N. S., Wang J. et al., 2019. BMC Nephrol, 20 (1) p. 125.
[URN][DOI][Pmid][serval:BIB_F904E21832BE]
2018
 
In Reply to 'Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy'
Le Quintrec M., Fremeaux-Bacchi V., Fakhouri F., 2018/12. Am J Kidney Dis, 72 (6) pp. 906-907.
[DOI][Pmid][serval:BIB_AF35AC5F4C63]
 
Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation
Neel A., Espitia-Thibault A., Arrigoni P. P., Volteau C., Rimbert M., Masseau A., Agard C., Fakhouri F., Liberge R., Hamidou M., 2018/08. Semin Arthritis Rheum, 48 (1) pp. 70-76.
[DOI][Pmid][serval:BIB_0EE441413ADF]
 
Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome
Schaefer F., Ardissino G., Ariceta G., Fakhouri F., Scully M., Isbel N., Lommele A., Kupelian V., Gasteyger C., Greenbaum L. A. et al., 2018/08. Kidney Int, 94 (2) pp. 408-418.
[DOI][Pmid][serval:BIB_4ECC5658F6DD]
 
Anticomplement Treatment in Atypical and Typical Hemolytic Uremic Syndrome
Fakhouri F., Loirat C., 2018/07. Semin Hematol, 55 (3) pp. 150-158.
[DOI][Pmid][serval:BIB_FE7425F24F9D]
 
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
Le Quintrec M., Lapeyraque A. L., Lionet A., Sellier-Leclerc A. L., Delmas Y., Baudouin V., Daugas E., Decramer S., Tricot L., Cailliez M. et al., 2018/07. Am J Kidney Dis, 72 (1) pp. 84-92.
[DOI][Pmid][serval:BIB_2A577D725E68]
2017
 
[Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics]
Rafat C., Coppo P., Fakhouri F., Fremeaux-Bacchi V., Loirat C., Zuber J., Rondeau E., 2017/12. Rev Med Interne, 38 (12) pp. 817-824.
[DOI][Pmid][serval:BIB_5350EAF687CF]
 
[Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis]
Rafat C., Coppo P., Fakhouri F., Fremeaux-Bacchi V., Loirat C., Zuber J., Rondeau E., 2017/12. Rev Med Interne, 38 (12) pp. 833-839.
[DOI][Pmid][serval:BIB_CAEF0C54AA4E]
 
Pregnancy-related acute kidney injury in high income countries: still a critical issue
Fakhouri F., Deltombe C., 2017/12. J Nephrol, 30 (6) pp. 767-771.
[DOI][Pmid][serval:BIB_E805F990A26D]
 
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
Marinozzi M. C., Chauvet S., Le Quintrec M., Mignotet M., Petitprez F., Legendre C., Cailliez M., Deschenes G., Fischbach M., Karras A. et al., 2017/11. Kidney Int, 92 (5) pp. 1232-1241.
[DOI][Pmid][serval:BIB_A3CE4A723109]
 
Haemolytic uraemic syndrome.
Fakhouri F., Zuber J., Frémeaux-Bacchi V., Loirat C., 2017/08/12. Lancet, 390 (10095) pp. 681-696. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3702CCF03CEE]
 
Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28
Laurent L., Le Fur A., Bloas R. L., Neel M., Mary C., Moreau A., Poirier N., Vanhove B., Fakhouri F., 2017/08. Eur J Immunol, 47 (8) pp. 1368-1376.
[DOI][Pmid][serval:BIB_7B5D1E5F2504]
 
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
Kleinmann J. F., Tubach F., Le Guern V., Mathian A., Richez C., Saadoun D., Sacre K., Sellam J., Seror R., Amoura Z. et al., 2017/06. Autoimmun Rev, 16 (6) pp. 650-657.
[DOI][Pmid][serval:BIB_B023E341690A]
 
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Goodship T. H., Cook H. T., Fakhouri F., Fervenza F. C., Fremeaux-Bacchi V., Kavanagh D., Nester C. M., Noris M., Pickering M. C., Rodriguez de Cordoba S. et al., 2017/03. Kidney Int, 91 (3) pp. 539-551.
[DOI][Pmid][serval:BIB_E055B6E85E1A]
Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders
Vanhove B., Poirier N., Fakhouri F., Laurent L., t Hart B., Papotto P. H., Rizzo L. V., Zaitsu M., Issa F., Wood K. et al., 2017. Antibodies (Basel), 6 (4).
[URN][DOI][Pmid][serval:BIB_7291979F12C3]
 
Hemolytic Uremic Syndrome in Pregnancy and Postpartum
Bruel A., Kavanagh D., Noris M., Delmas Y., Wong E. K. S., Bresin E., Provot F., Brocklebank V., Mele C., Remuzzi G. et al., 2017. Clin J Am Soc Nephrol, 12 (8) pp. 1237-1247.
[DOI][Pmid][serval:BIB_A01F3BD9971C]
 
Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation
Fakhouri F., Fila M., Provot F., Delmas Y., Barbet C., Chatelet V., Rafat C., Cailliez M., Hogan J., Servais A. et al., 2017. Clin J Am Soc Nephrol, 12 (1) pp. 50-59.
[DOI][Pmid][serval:BIB_9BCB6E4C4EFE]
2016
 
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial
Fakhouri F., Hourmant M., Campistol J. M., Cataland S. R., Espinosa M., Gaber A. O., Menne J., Minetti E. E., Provot F., Rondeau E. et al., 2016/07. Am J Kidney Dis, 68 (1) pp. 84-93.
[DOI][Pmid][serval:BIB_3742DA836A71]
 
[Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases]
Lioger B., Yahiaoui Y., Kahn J. E., Fakhouri F., Belenfant X., Papo T., Magnant J., Maillot F., Vordos D., Godeau B. et al., 2016/06. Rev Med Interne, 37 (6) pp. 387-93.
[DOI][Pmid][serval:BIB_B5C07B70C469]
 
[Clinical approach to primary membranoproliferative glomerulonephritis]
Fakhouri F., 2016/04. Nephrol Ther, 12 Suppl 1 pp. S65-9.
[DOI][Pmid][serval:BIB_3AE5F53EF448]
 
Pregnancy-related thrombotic microangiopathies: Clues from complement biology
Fakhouri F., 2016/04. Transfus Apher Sci, 54 (2) pp. 199-202.
[DOI][Pmid][serval:BIB_106FC70055D7]
 
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
Loirat C., Fakhouri F., Ariceta G., Besbas N., Bitzan M., Bjerre A., Coppo R., Emma F., Johnson S., Karpman D. et al., 2016/01. Pediatr Nephrol, 31 (1) pp. 15-39.
[DOI][Pmid][serval:BIB_DC2F8EFC4257]
 
Translational implications of endothelial cell dysfunction in association with chronic allograft rejection
Bruneau S., Wedel J., Fakhouri F., Nakayama H., Boneschansker L., Irimia D., Daly K. P., Briscoe D. M., 2016/01. Pediatr Nephrol, 31 (1) pp. 41-51.
[DOI][Pmid][serval:BIB_33C6FA51CAB9]
2015
 
Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation
Le Berre L., Dufay A., Cantarovich D., Meurette A., Audrain M., Giral M., Blancho G., Fakhouri F., Hourmant M., Dantal J., 2015/06. Clin Nephrol, 83 (6) pp. 357-62.
[DOI][Pmid][serval:BIB_9F301F84BD03]
 
Eculizumab for treatment of rapidly progressive C3 glomerulopathy
Le Quintrec M., Lionet A., Kandel C., Bourdon F., Gnemmi V., Colombat M., Goujon J. M., Fremeaux-Bacchi V., Fakhouri F., 2015/03. Am J Kidney Dis, 65 (3) pp. 484-9.
[DOI][Pmid][serval:BIB_C82ABEF7B5FA]
 
Loss of DGKepsilon induces endothelial cell activation and death independently of complement activation
Bruneau S., Neel M., Roumenina L. T., Frimat M., Laurent L., Fremeaux-Bacchi V., Fakhouri F., 2015. Blood, 125 (6) pp. 1038-46.
[DOI][Pmid][serval:BIB_41EB8D040D5A]
2014
 
Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance
Guitard J., Hebral A. L., Fakhouri F., Joly D., Daugas E., Rivalan J., Guigonis V., Ducret F., Presne C., Pirson Y. et al., 2014/11. Nephrol Dial Transplant, 29 (11) pp. 2084-91.
[DOI][Pmid][serval:BIB_7B09C484785D]
 
Malignancy and thrombotic microangiopathy or atypical haemolytic and uraemic syndrome?
Favre G. A., Touzot M., Fremeaux-Bacchi V., Hyvernat H., Gueffet J. P., Rohrlich P. S., Queyrel V., Esnault V., Fakhouri F., 2014/09. Br J Haematol, 166 (5) pp. 802-5.
[DOI][Pmid][serval:BIB_657A54C83025]
 
Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1
Lavainne F., Meffray E., Pepper R. J., Neel M., Delcroix C., Salama A. D., Fakhouri F., 2014/06. Nephrol Dial Transplant, 29 (6) pp. 1225-31.
[DOI][Pmid][serval:BIB_F33F41FF184E]
 
Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches
Riedl M., Fakhouri F., Le Quintrec M., Noone D. G., Jungraithmayr T. C., Fremeaux-Bacchi V., Licht C., 2014/06. Semin Thromb Hemost, 40 (4) pp. 444-64.
[DOI][Pmid][serval:BIB_E8592A26C04A]
 
Long-term outcome of monoclonal (type 1) cryoglobulinemia
Neel A., Perrin F., Decaux O., Dejoie T., Tessoulin B., Halliez M., Mahe B., Lamy T., Fakhouri F., Jego P. et al., 2014/02. Am J Hematol, 89 (2) pp. 156-61.
[DOI][Pmid][serval:BIB_F0F61F73F24E]
 
Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases
Fakhouri F., Delmas Y., Provot F., Barbet C., Karras A., Makdassi R., Courivaud C., Rifard K., Servais A., Allard C. et al., 2014/01. Am J Kidney Dis, 63 (1) pp. 40-8.
[DOI][Pmid][serval:BIB_8CEB2913341B]
The spectrum of renal involvement in patients with inflammatory myopathies
Couvrat-Desvergnes G., Masseau A., Benveniste O., Bruel A., Hervier B., Mussini J. M., Buob D., Hachulla E., Remy P., Azar R. et al., 2014/01. Medicine (Baltimore), 93 (1) pp. 33-41.
[URN][DOI][Pmid][serval:BIB_F6CC2AEA9E23]
2013
C3 glomerulopathy: consensus report
Pickering M. C., D'Agati V. D., Nester C. M., Smith R. J., Haas M., Appel G. B., Alpers C. E., Bajema I. M., Bedrosian C., Braun M. et al., 2013/12. Kidney Int, 84 (6) pp. 1079-89.
[URN][DOI][Pmid][serval:BIB_D033D6592E29]
 
Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen
Allavena C., Bach-Ngohou K., Billaud E., Secher S., Dejoie T., Reliquet V., Fakhouri F., Raffi F., 2013/12. J Antimicrob Chemother, 68 (12) pp. 2866-70.
[DOI][Pmid][serval:BIB_AEFB9AEE2739]
 
Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy
Fakhouri F., Fremeaux-Bacchi V., Loirat C., 2013/09. Eur J Intern Med, 24 (6) pp. 492-5.
[DOI][Pmid][serval:BIB_F58C4C20E4EF]
 
Thrombotic microangiopathy: eculizumab for atypical haemolytic uraemic syndrome: what next?
Fakhouri F., Fremeaux-Bacchi V., 2013/09. Nat Rev Nephrol, 9 (9) pp. 495-6.
[DOI][Pmid][serval:BIB_6AD330B5FF54]
 
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.
Lemaire M., Frémeaux-Bacchi V., Schaefer F., Choi M., Tang W.H., Le Quintrec M., Fakhouri F., Taque S., Nobili F., Martinez F. et al., 2013/05. Nature genetics, 45 (5) pp. 531-536. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_43275A1785F5]
 
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
Fremeaux-Bacchi V., Fakhouri F., Garnier A., Bienaimé F., Dragon-Durey M.A., Ngo S., Moulin B., Servais A., Provot F., Rostaing L. et al., 2013/04. Clinical journal of the American Society of Nephrology, 8 (4) pp. 554-562. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9666DA6AF4AA]
 
Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome.
Sallée M., Ismail K., Fakhouri F., Vacher-Coponat H., Moussi-Francés J., Frémaux-Bacchi V., Burtey S., 2013/01/08. BMC nephrology, 14 p. 3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_17313072E5D7]
 
Increased soluble Flt-1 correlates with delayed graft function and early loss of peritubular capillaries in the kidney graft
Chapal M., Neel M., Le Borgne F., Meffray E., Carceles O., Hourmant M., Giral M., Foucher Y., Moreau A., Fakhouri F., 2013. Transplantation, 96 (8) pp. 739-44.
[DOI][Pmid][serval:BIB_B23A6CD6EDA0]
2012
 
Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy
Fakhouri F., Vercel C., Fremeaux-Bacchi V., 2012/12. Clin J Am Soc Nephrol, 7 (12) pp. 2100-6.
[DOI][Pmid][serval:BIB_41D945BCB50D]
 
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
Zuber J., Fakhouri F., Roumenina L. T., Loirat C., Fremeaux-Bacchi V., French Study Group for a Hus C. G., 2012/11. Nat Rev Nephrol, 8 (11) pp. 643-57.
[DOI][Pmid][serval:BIB_6B2B665F8EC9]
 
Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study
Chapal M., Debout A., Dufay A., Salomon R., Roussey G., Burtey S., Launay E. A., Vigneau C., Blancho G., Loirat C. et al., 2012/05. Nephrol Dial Transplant, 27 (5) pp. 2083-8.
[DOI][Pmid][serval:BIB_36B98DA3253C]
 
Hyponatremia and mortality in patients with cancer: the devil is in the details
Fakhouri F., Lavainne F., Karras A., 2012/02. Am J Kidney Dis, 59 (2) pp. 168-9.
[DOI][Pmid][serval:BIB_0D76025EF501]
 
Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis
Le Roux S., Pepper R. J., Dufay A., Neel M., Meffray E., Lamande N., Rimbert M., Josien R., Hamidou M., Hourmant M. et al., 2012/01. J Am Soc Nephrol, 23 (1) pp. 155-64.
[DOI][Pmid][serval:BIB_86B7B0D2F5BD]
2011
 
[Why and how to promote peritoneal dialysis?]
Ryckelynck J. P., Abbadie O., Castrale C., Lavainne F., Fakhouri F., Lobbedez T., 2011/11. Presse Med, 40 (11) pp. 1053-8.
[DOI][Pmid][serval:BIB_7A6545B62525]
 
Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab
Guiard E., Karras A., Plaisier E., Duong Van Huyen J. P., Fakhouri F., Rougier J. P., Noel L. H., Callard P., Delahousse M., Ronco P., 2011/07. Clin J Am Soc Nephrol, 6 (7) pp. 1609-16.
[DOI][Pmid][serval:BIB_0D928C313D05]
 
[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system]
Fremeaux-Bacchi V., Fakhouri F., Roumenina L., Dragon-Durey M. A., Loirat C., 2011/04. Rev Med Interne, 32 (4) pp. 232-40.
[DOI][Pmid][serval:BIB_1F62F4C3A2CF]
 
Endothelin-1 expression in scleroderma renal crisis
Mouthon L., Mehrenberger M., Teixeira L., Fakhouri F., Berezne A., Guillevin L., Noel L. H., 2011/01. Hum Pathol, 42 (1) pp. 95-102.
[DOI][Pmid][serval:BIB_E3E0B84CF39C]
2010
 
C3 glomerulopathy: a new classification
Fakhouri F., Fremeaux-Bacchi V., Noel L. H., Cook H. T., Pickering M. C., 2010/08. Nat Rev Nephrol, 6 (8) pp. 494-9.
[DOI][Pmid][serval:BIB_82C5C0C13E04]
 
Fanconi syndrome in lymphoma patients: report of the first case series
Vanmassenhove J., Sallee M., Guilpain P., Vanholder R., De Potter A., Libbrecht L., Suarez F., Hermine O., Fakhouri F., 2010/08. Nephrol Dial Transplant, 25 (8) pp. 2516-20.
[DOI][Pmid][serval:BIB_5DBBCC74770C]
 
Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice
Fakhouri F., de Jorge E. G., Brune F., Azam P., Cook H. T., Pickering M. C., 2010/08. Kidney Int, 78 (3) pp. 279-86.
[DOI][Pmid][serval:BIB_B0A0054F219E]
 
Down syndrome maternal serum screening in patients with renal disease
Benachi A., Dreux S., Kaddioui-Maalej S., Czerkiewicz I., Fakhouri F., Thervet E., Muller F., 2010/07. Am J Obstet Gynecol, 203 (1) pp. 60 e1-4.
[DOI][Pmid][serval:BIB_CFEED1368EBF]
 
Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations
Fakhouri F., Roumenina L., Provot F., Sallee M., Caillard S., Couzi L., Essig M., Ribes D., Dragon-Durey M. A., Bridoux F. et al., 2010/05. J Am Soc Nephrol, 21 (5) pp. 859-67.
[DOI][Pmid][serval:BIB_A7BA6CAF7A19]
 
Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study
Touzot M., Elie C., van Massenhove J., Maillard N., Buzyn A., Fakhouri F., 2010/02. Nephrol Dial Transplant, 25 (2) pp. 624-7.
[DOI][Pmid][serval:BIB_45D4F3CF8741]
 
Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist
Ghoul B. E., Squalli T., Servais A., Elie C., Meas-Yedid V., Trivint C., Vanmassenhove J., Grunfeld J. P., Olivo-Marin J. C., Thervet E. et al., 2010/02. Clin J Am Soc Nephrol, 5 (2) pp. 205-10.
[DOI][Pmid][serval:BIB_93DB71DC8AF2]
 
Severe renal failure in acute bacterial pyelonephritis: do not forget corticosteroids
Sqalli T. H., Hamzaoui H., Guiard E., Noel L. H., Fakhouri F., 2010/01. Saudi J Kidney Dis Transpl, 21 (1) pp. 118-22.
[Pmid][serval:BIB_FA816EB27B4B]
2009
 
Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection
Matignon M., Cacoub P., Colombat M., Saadoun D., Brocheriou I., Mougenot B., Roudot-Thoraval F., Vanhille P., Moranne O., Hachulla E. et al., 2009/11. Medicine (Baltimore), 88 (6) pp. 341-348.
[DOI][Pmid][serval:BIB_AB0FB62F4207]
 
Fanconi syndrome due to deferasirox
Rafat C., Fakhouri F., Ribeil J. A., Delarue R., Le Quintrec M., 2009/11. Am J Kidney Dis, 54 (5) pp. 931-4.
[DOI][Pmid][serval:BIB_9137E0185967]
 
Cyst infections in patients with autosomal dominant polycystic kidney disease
Sallee M., Rafat C., Zahar J. R., Paulmier B., Grunfeld J. P., Knebelmann B., Fakhouri F., 2009/07. Clin J Am Soc Nephrol, 4 (7) pp. 1183-9.
[DOI][Pmid][serval:BIB_C602C46BEA40]
Late recovery of renal failure after autologous haematopoietic stem cell transplantation for multiple myeloma: a report of two cases
Bige N., Guery B., Delarue R., Noel L. H., Fakhouri F., 2009/06. NDT Plus, 2 (3) pp. 242-5.
[URN][DOI][Pmid][serval:BIB_F3E4C4C8DF62]
 
Pauci-immune crescentic glomerulonephritis associated with ANCA of IgA class
Bollee G., Noel L. H., Suarez F., Royal V., Gilardin L., de Serre N. P., El-Ghoul B., Lesavre P., Alyanakian M. A., Fakhouri F., 2009/06. Am J Kidney Dis, 53 (6) pp. 1063-7.
[DOI][Pmid][serval:BIB_ED2DAE9A9AD6]
 
Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance
Yahiaoui Y., Jablonski M., Hubert D., Mosnier-Pudar H., Noel L. H., Stern M., Grenet D., Grunfeld J. P., Chauveau D., Fakhouri F., 2009/05. Clin J Am Soc Nephrol, 4 (5) pp. 921-8.
[DOI][Pmid][serval:BIB_7A2C2F95814D]
 
Multiple OXPHOS deficiency in the liver of a patient with CblA methylmalonic aciduria sensitive to vitamin B(12)
Valayannopoulos V., Hubert L., Benoist J. F., Romano S., Arnoux J. B., Chretien D., Kaplan J., Fakhouri F., Rabier D., Rotig A. et al., 2009/04. J Inherit Metab Dis, 32 (2) pp. 159-62.
[DOI][Pmid][serval:BIB_278E46C12E6B]
 
Plasma exchange for disseminated cryptococcosis
Bollee G., Touzot M., Mechai F., Royal V., Lefrere F., Bougnoux M. E., Duvivier C., Viard J. P., Lortholary O., Fakhouri F., 2009/04. Am J Kidney Dis, 53 (4) pp. 673-6.
[DOI][Pmid][serval:BIB_E23075D9A39B]
Urinary tract obstruction due to extramedullary plasmacytoma: report of two cases
Bige N., Arnulf B., Hummel A., De Keyser E., Royal V., Buzyn A., Fakhouri F., 2009/04. NDT Plus, 2 (2) pp. 143-6.
[URN][DOI][Pmid][serval:BIB_BC4FFAD0F0FA]
 
Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome
Melander C., Sallee M., Trolliet P., Candon S., Belenfant X., Daugas E., Remy P., Zarrouk V., Pillebout E., Jacquot C. et al., 2009/03. Clin J Am Soc Nephrol, 4 (3) pp. 579-87.
[DOI][Pmid][serval:BIB_EECD3AA8B0FD]
 
Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib
Bollee G., Patey N., Cazajous G., Robert C., Goujon J. M., Fakhouri F., Bruneval P., Noel L. H., Knebelmann B., 2009/02. Nephrol Dial Transplant, 24 (2) pp. 682-5.
[DOI][Pmid][serval:BIB_DBD1A5BE2D97]
2008
 
Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum
Audard V., Georges B., Vanhille P., Toly C., Deroure B., Fakhouri F., Cuvelier R., Belenfant X., Surin B., Aucouturier P. et al., 2008/09. Clin J Am Soc Nephrol, 3 (5) pp. 1339-49.
[DOI][Pmid][serval:BIB_84A2D1DC221B]
 
Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation
Le Quintrec M., Lionet A., Kamar N., Karras A., Barbier S., Buchler M., Fakhouri F., Provost F., Fridman W. H., Thervet E. et al., 2008/08. Am J Transplant, 8 (8) pp. 1694-701.
[DOI][Pmid][serval:BIB_5733001D805A]
 
Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy
Camous L., Melander C., Vallet M., Squalli T., Knebelmann B., Noel L. H., Fakhouri F., 2008/08. Am J Kidney Dis, 52 (2) pp. 346-52.
[DOI][Pmid][serval:BIB_CD425C453CD6]
 
Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease
Soussan M., Sberro R., Wartski M., Fakhouri F., Pecking A. P., Alberini J. L., 2008/07. Ann Nucl Med, 22 (6) pp. 529-31.
[DOI][Pmid][serval:BIB_5A18928D36D0]
 
Presentation and outcome of patients with systemic amyloidosis undergoing dialysis
Bollee G., Guery B., Joly D., Snanoudj R., Terrier B., Allouache M., Mercadal L., Peraldi M. N., Viron B., Fumeron C. et al., 2008/03. Clin J Am Soc Nephrol, 3 (2) pp. 375-81.
[DOI][Pmid][serval:BIB_B93EECE94B49]
 
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients
Terrier B., Jaccard A., Harousseau J. L., Delarue R., Tournilhac O., Hunault-Berger M., Hamidou M., Dantal J., Bernard M., Grosbois B. et al., 2008/03. Medicine (Baltimore), 87 (2) pp. 99-109.
[DOI][Pmid][serval:BIB_A2CACA1659FD]
 
Posterior reversible encephalopathy syndrome in systemic lupus erythematosus
El Karoui K., Le Quintrec M., Dekeyser E., Servais A., Hummel A., Fadel F., Fakhouri F., 2008/02. Nephrol Dial Transplant, 23 (2) pp. 757-63.
[DOI][Pmid][serval:BIB_79C1A2184021]
 
[Hemolytic-uremic syndrome: what is the mechanism?]
Fremeaux-Bacchi V., Fakhouri F., Loirat C., 2008. Rev Prat, 58 (19) pp. 2093-6.
[Pmid][serval:BIB_10AFC61417A5]
 
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome
Fakhouri F., Jablonski M., Lepercq J., Blouin J., Benachi A., Hourmant M., Pirson Y., Durrbach A., Grunfeld J. P., Knebelmann B. et al., 2008. Blood, 112 (12) pp. 4542-5.
[DOI][Pmid][serval:BIB_FFAC6FA82A1D]
 
Osteomalacia revealing celiac disease and primary biliary cirrhosis-related Fanconi syndrome in a patient with systemic sclerosis
Terrier B., Fakhouri F., Berezne A., Bouldouyre M. A., Guilpain P., Sogni P., Terris B., Noel L. H., Guillevin L., Mouthon L., 2008. Clin Exp Rheumatol, 26 (3) pp. 467-70.
[Pmid][serval:BIB_F6F8BCAD3980]
2007
 
Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?
Fakhouri F., Fremeaux-Bacchi V., 2007/12. Nat Clin Pract Nephrol, 3 (12) pp. 679-87.
[DOI][Pmid][serval:BIB_6684F6B375DB]
 
Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies
Brachemi S., Mambole A., Fakhouri F., Mouthon L., Guillevin L., Lesavre P., Halbwachs-Mecarelli L., 2007/08. J Am Soc Nephrol, 18 (8) pp. 2330-9.
[DOI][Pmid][serval:BIB_4AD4E4E82787]
 
[Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir]
Terrier B., Hummel A., Fakhouri F., Jablonski M., Hugle T., Gasnault J., Sanson M., Martinez F., 2007/07. Rev Med Interne, 28 (7) pp. 488-91.
[DOI][Pmid][serval:BIB_548058C201BC]
 
[Intravenous immunoglobulins and acute renal failure: mechanism and prevention]
Fakhouri F., 2007/05. Rev Med Interne, 28 Spec No. 1 pp. 4-6.
[Pmid][serval:BIB_FC8ACC692911]
 
Alagille syndrome in adult patients: it is never too late
Jacquet A., Guiochon-Mantel A., Noel L. H., Sqalli T., Bedossa P., Hadchouel M., Grunfeld J. P., Fakhouri F., 2007/05. Am J Kidney Dis, 49 (5) pp. 705-9.
[DOI][Pmid][serval:BIB_9656F2FE445A]
 
Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects
Terrier B., Delmas Y., Hummel A., Presne C., Glowacki F., Knebelmann B., Combe C., Lesavre P., Maillard N., Noel L. H. et al., 2007/05. Nephrol Dial Transplant, 22 (5) pp. 1369-76.
[DOI][Pmid][serval:BIB_D4533BB4F629]
 
Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor
Schleinitz N., Ebbo M., Mazodier K., Poullin P., Bernit E., Veit V., Veyradier A., Fakhouri F., Kaplanski G., Harle J. R., 2007/05. Am J Hematol, 82 (5) pp. 417-8.
[DOI][Pmid][serval:BIB_9A7A372B8DFA]
 
Severe FOXP3+ and naive T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency
Zuber J., Viguier M., Lemaitre F., Senee V., Patey N., Elain G., Geissmann F., Fakhouri F., Ferradini L., Julier C. et al., 2007/05. Gastroenterology, 132 (5) pp. 1694-704.
[DOI][Pmid][serval:BIB_19342523B83F]
 
Acute renal failure and febrile rash--infectious or not? Adult Kawasaki disease (KD)
El Karoui K., Servais A., Fadel F., Jablonski M., Fakhouri F., Lesavre P., Hummel A., 2007/03. Nephrol Dial Transplant, 22 (3) pp. 949-51.
[DOI][Pmid][serval:BIB_20762E31B399]
 
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome
Servais A., Fremeaux-Bacchi V., Lequintrec M., Salomon R., Blouin J., Knebelmann B., Grunfeld J. P., Lesavre P., Noel L. H., Fakhouri F., 2007/03. J Med Genet, 44 (3) pp. 193-9.
[DOI][Pmid][serval:BIB_4559AD33FDD9]
 
An unusual cause of lymph nodes enlargement
Terrier B., Hummel A., Servais A., Delarue R., Fournier P., Fakhouri F., 2007/01. Am J Med, 120 (1) pp. e1-3.
[DOI][Pmid][serval:BIB_64586C730EE0]
 
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity
Ferrari S., Scheiflinger F., Rieger M., Mudde G., Wolf M., Coppo P., Girma J. P., Azoulay E., Brun-Buisson C., Fakhouri F. et al., 2007. Blood, 109 (7) pp. 2815-22.
[DOI][Pmid][serval:BIB_85FEBC282860]
2006
 
Serum monoclonal component and nephrotic syndrome--it is not always amyloidosis. Diagnosis: WM complicated by retroperitoneal and renal infiltration and associated with a minimal change disease
Terrier B., Buzyn A., Hummel A., Deroure B., Bollee G., Jablonski M., de Serre N. P., Noel L. H., Fakhouri F., 2006/11. Nephrol Dial Transplant, 21 (11) pp. 3327-9.
[DOI][Pmid][serval:BIB_B6055E5E6838]
 
Primary bilateral diffuse renal lymphoma
Guilpain P., Delarue R., Matignon M., Noel L. H., Knebelmann B., Fakhouri F., 2006/10. Am J Hematol, 81 (10) pp. 804-5.
[DOI][Pmid][serval:BIB_A4E53570CD76]
 
Nephronophthisis related to homozygous NPHP1 gene deletion as a cause of chronic renal failure in adults
Bollee G., Fakhouri F., Karras A., Noel L. H., Salomon R., Servais A., Lesavre P., Moriniere V., Antignac C., Hummel A., 2006/09. Nephrol Dial Transplant, 21 (9) pp. 2660-3.
[DOI][Pmid][serval:BIB_1D81F5170C5F]
 
Plasmacytoma in a multiple myeloma patient
Jablonski M., Servais A., Suarez F., Fakhouri F., 2006/09. Br J Haematol, 134 (5) p. 451.
[DOI][Pmid][serval:BIB_5F65F98E039C]
 
[Urinary erythropoietin excretion: an unknown cause of anemia during nephrotic syndrome]
Terrier B., Fakhouri F., Sultanik P., Delarue R., Hummel A., 2006/08. Rev Med Interne, 27 (8) pp. 643-5.
[DOI][Pmid][serval:BIB_2455EDAB0BA0]
 
Nephrotic syndrome associated with hemophagocytic syndrome
Thaunat O., Delahousse M., Fakhouri F., Martinez F., Stephan J. L., Noel L. H., Karras A., 2006/05. Kidney Int, 69 (10) pp. 1892-8.
[DOI][Pmid][serval:BIB_80CBA56AE489]
 
Reversible paraparesis in multiple myeloma with renal failure
Terrier B., Joly D., Ghez D., Knebelmann B., Fakhouri F., Hummel A., 2006/05. Nephrol Dial Transplant, 21 (5) pp. 1439-40.
[DOI][Pmid][serval:BIB_AD3561BC182E]
 
Rituximab therapy for childhood-onset systemic lupus erythematosus
Willems M., Haddad E., Niaudet P., Kone-Paut I., Bensman A., Cochat P., Deschenes G., Fakhouri F., Leblanc T., Llanas B. et al., 2006/05. J Pediatr, 148 (5) pp. 623-627.
[DOI][Pmid][serval:BIB_2404C2059AC2]
 
Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis
Daniel L., Fakhouri F., Joly D., Mouthon L., Nusbaum P., Grunfeld J. P., Schifferli J., Guillevin L., Lesavre P., Halbwachs-Mecarelli L., 2006/04. Kidney Int, 69 (8) pp. 1416-23.
[DOI][Pmid][serval:BIB_A4CD8B6D7DAC]
 
A new treatment for TTP?
Fakhouri F., Deroure B., Hummel A., 2006/03. Nephrol Dial Transplant, 21 (3) pp. 577-9.
[DOI][Pmid][serval:BIB_1ABC34F93238]
2005
 
Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis
Lino M., Binaut R., Noel L. H., Patey N., Rustin P., Daniel L., Serpaggi J., Varaut A., Vanhille P., Knebelmann B. et al., 2005/09. Am J Kidney Dis, 46 (3) pp. e41-6.
[DOI][Pmid][serval:BIB_E25E4A57FCC6]
 
ANCA-negative pauci-immune renal vasculitis: histology and outcome
Eisenberger U., Fakhouri F., Vanhille P., Beaufils H., Mahr A., Guillevin L., Lesavre P., Noel L. H., 2005/07. Nephrol Dial Transplant, 20 (7) pp. 1392-9.
[DOI][Pmid][serval:BIB_74F9EC3A2537]
 
Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature
Karras A., de Montpreville V., Fakhouri F., Grunfeld J. P., Lesavre P., Groupe d'Etudes des Nephropathies Associees aux Thymomes, 2005/06. Nephrol Dial Transplant, 20 (6) pp. 1075-82.
[DOI][Pmid][serval:BIB_5F3E417567C9]
 
Type III cryoglobulinemia complicated by renal cortical necrosis
Thaunat O., Aaron L., Desbene C., Noel L. H., Karras A., Lesavre P., Alyanakian M. A., Fakhouri F., 2005/05. Am J Kidney Dis, 45 (5) pp. e79-81.
[DOI][Pmid][serval:BIB_FB76755ED3B8]
 
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases
Fakhouri F., Vernant J. P., Veyradier A., Wolf M., Kaplanski G., Binaut R., Rieger M., Scheiflinger F., Poullin P., Deroure B. et al., 2005. Blood, 106 (6) pp. 1932-7.
[DOI][Pmid][serval:BIB_5C461F466F36]
 
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report
Galbusera M., Bresin E., Noris M., Gastoldi S., Belotti D., Capoferri C., Daina E., Perseghin P., Scheiflinger F., Fakhouri F. et al., 2005. Blood, 106 (3) pp. 925-8.
[DOI][Pmid][serval:BIB_C2C0E6F1D749]
2004
 
Thalidomide in patients with multiple myeloma and renal failure
Fakhouri F., Guerraoui H., Presne C., Peltier J., Delarue R., Muret P., Knebelmann B., 2004/04. Br J Haematol, 125 (1) pp. 96-7.
[DOI][Pmid][serval:BIB_11B95F999E12]
 
Angiotensin-converting enzyme inhibitors for secondary erythrocytosis
Fakhouri F., Grunfeld J. P., Hermine O., Delarue R., 2004. Ann Intern Med, 140 (6) pp. 492-3.
[DOI][Pmid][serval:BIB_F49A6385FF75]
 
Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide
Fakhouri F., Teixeira L., Delarue R., Grunfeld J. P., Veyradier A., 2004. Ann Intern Med, 140 (4) pp. 314-5.
[DOI][Pmid][serval:BIB_82089943EBCF]
 
The man with "milk-shake" urine
Fakhouri F., Matignon M., Therby A., Mejean A., Correas J. M., Challier S., Knebelmann B., 2004. Lancet, 364 (9445) p. 1638.
[DOI][Pmid][serval:BIB_804D63CEA53D]
 
Thrombotic microangiopathy and hypothermia in an HIV-positive patient: importance of cytomegalovirus infection
Rerolle J. P., Canaud G., Fakhouri F., Aaron L., Morelon E., Peraldi M. N., Kreis H., Bruneel M. F., 2004. Scand J Infect Dis, 36 (3) pp. 234-7.
[DOI][Pmid][serval:BIB_1D9A39CA61AA]
2003
 
Lithium-induced nephropathy: Rate of progression and prognostic factors
Presne C., Fakhouri F., Noel L. H., Stengel B., Even C., Kreis H., Mignon F., Grunfeld J. P., 2003/08. Kidney Int, 64 (2) pp. 585-92.
[DOI][Pmid][serval:BIB_AB015F08BE60]
 
The expanding spectrum of renal diseases associated with antiphospholipid syndrome
Fakhouri F., Noel L. H., Zuber J., Beaufils H., Martinez F., Lebon P., Papo T., Chauveau D., Bletry O., Grunfeld J. P. et al., 2003/06. Am J Kidney Dis, 41 (6) pp. 1205-11.
[DOI][Pmid][serval:BIB_CDD31269C823]
 
Steroid-sensitive nephrotic syndrome: from childhood to adulthood
Fakhouri F., Bocquet N., Taupin P., Presne C., Gagnadoux M. F., Landais P., Lesavre P., Chauveau D., Knebelmann B., Broyer M. et al., 2003/03. Am J Kidney Dis, 41 (3) pp. 550-7.
[DOI][Pmid][serval:BIB_0130C13F21BF]
2002
 
Crystals from fat. Acute oxalate nephropathy
Fakhouri F., Chauveau D., Touam M., Noel L. H., Grunfeld J. P., 2002/07. Nephrol Dial Transplant, 17 (7) pp. 1348-50.
[DOI][Pmid][serval:BIB_C822A4661B07]
 
Mesangial IgG glomerulonephritis: a distinct type of primary glomerulonephritis
Fakhouri F., Darre S., Droz D., Lemaire M., Nabarra B., Machet M. C., Chauveau D., Lesavre P., Grunfeld J. P., Noel L. H. et al., 2002/02. J Am Soc Nephrol, 13 (2) pp. 379-387.
[DOI][Pmid][serval:BIB_ABADCC1AC156]
 
[Multiple kidney cysts]
Fakhouri F., Knebelmann B., 2002. Rev Prat, 52 (20) pp. 2273-7.
[Pmid][serval:BIB_EBE95400BED7]
 
[Progressive renal failure caused by lithium nephropathy]
Presne C., Fakhouri F., Kenouch S., Stengel B., Kreis H., Grunfeld J. P., 2002. Presse Med, 31 (18) pp. 828-33.
[Pmid][serval:BIB_C49A4B0A5DCD]
 
[Vasoactive peptides and the development of renal sclerosis: contribution of transgenes]
Dussaule J. C., Boffa J. J., Tharaux P. L., Flamant M., Fakhouri F., Chatziantoniou C., 2002. J Soc Biol, 196 (4) pp. 275-80.
[Pmid][serval:BIB_CD9068367D54]
2001
 
Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta
Fakhouri F., Placier S., Ardaillou R., Dussaule J. C., Chatziantoniou C., 2001/12. J Am Soc Nephrol, 12 (12) pp. 2701-2710.
[DOI][Pmid][serval:BIB_31635A1E44D2]
 
Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients
Jungers P., Massy Z. A., Nguyen-Khoa T., Choukroun G., Robino C., Fakhouri F., Touam M., Nguyen A. T., Grunfeld J. P., 2001/12. Nephrol Dial Transplant, 16 (12) pp. 2357-64.
[DOI][Pmid][serval:BIB_897539E2F526]
 
Granulomatous renal disease in a patient with common variable immunodeficiency
Fakhouri F., Robino C., Lemaire M., Droz D., Noel L. H., Knebelmann B., Lesavre P., 2001/08. Am J Kidney Dis, 38 (2) pp. E7.
[DOI][Pmid][serval:BIB_15F6D9D7130C]
 
Presentation and revascularization outcomes in patients with radiation-induced renal artery stenosis
Fakhouri F., La Batide Alanore A., Rerolle J. P., Guery B., Raynaud A., Plouin P. F., 2001/08. Am J Kidney Dis, 38 (2) pp. 302-9.
[DOI][Pmid][serval:BIB_8021CAA5AB7A]
 
Hereditary nephritis with macrothrombocytopenia: no longer an Alport syndrome variant
Knebelmann B., Fakhouri F., Grunfeld J. P., 2001/06. Nephrol Dial Transplant, 16 (6) pp. 1101-3.
[DOI][Pmid][serval:BIB_CB5EF958913A]
 
[Course of chronic renal failure epidemiology and prediction of maintenance dialysis needs in France]
Jungers P., Robino C., Choukroun G., Touam M., Fakhouri F., Grunfeld J. P., 2001. Nephrologie, 22 (3) pp. 91-7.
[Pmid][serval:BIB_BD5F93ED8123]
2000
 
Mechanisms mediating the renal profibrotic actions of vasoactive peptides in transgenic mice
Dussaule J. C., Tharaux P. L., Boffa J. J., Fakhouri F., Ardaillou R., Chatziantoniou C., 2000/11. J Am Soc Nephrol, 11 Suppl 16 pp. S124-8.
[Pmid][serval:BIB_5380DD959F85]
 
Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway
Tharaux P. L., Chatziantoniou C., Fakhouri F., Dussaule J. C., 2000/09. Hypertension, 36 (3) pp. 330-6.
[DOI][Pmid][serval:BIB_D8660C92B342]
 
Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma
Chauveau D., Fakhouri F., Grunfeld J. P., 2000/09. J Am Soc Nephrol, 11 (9) pp. 1767-1775.
[DOI][Pmid][serval:BIB_D8DDC20B6C34]
 
Therapeutic plasma exchange.
Fakhouri F., Vincent F., Legendre C., 2000/05/02. Annals of internal medicine, 132 (9) pp. 760-761. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9B722636D6FC]
 
Pathological and therapeutic distinctions in HUS/TTP.
Fakhouri F., Vincent F., Legendre C., 2000/02/05. Lancet, 355 (9202) p. 497. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E6BE54B30F8]
 
Endothelin, renal diseases, and hypertension
Dussaule J. C., Boffa J. J., Tharaux P. L., Fakhouri F., Ardaillou R., Chatziantoniou C., 2000. Adv Nephrol Necker Hosp, 30 pp. 281-303.
[Pmid][serval:BIB_2F790ABABDDA]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University